ADVL1921: A Phase 1 study to evaluate the safety and pharmacokinetics of palbociclib (IBRANCE®) in combination with irinotecan and temozolomide in pediatric patients with recurrent or refractory solid tumors

Project: Research project

Project Details

StatusActive
Effective start/end date6/25/208/31/50

Funding

  • Children's Hospital of Philadelphia
  • Pfizer Inc.